FDA
-
-
-
-
-
-
-
Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026
-
-
-
-
-
-
-
Niagen Bioscience Announces $10 Million Share Repurchase Program
-
-
-
-
-
-
-
AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+
-
-
-
-
-
-
-
Niagen Bioscience (NAGE) stock rises following positive clinical study
-
-
-
-
-
-
-
Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide
-
-
-
-
-
-
-
Niagen Bioscience (NAGE) Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

